Effects of ω -3 PUFAs supplementation on myocardial function and oxidative stress markers in typical rett syndrome

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Maffei, Silvia ^a   De Felice, Claudio ^a   Cannarile, Pierpaolo ^b   Leoncini, Silvia ^a,b   Signorini, Cinzia ^b   Pecorelli, Alessandra ^a,b   Montomoli, Barbara ^a   Lunghetti, Stefano ^a   Ciccoli, Lucia ^b   Durand, Thierry ^c   Favilli, Roberto ^a   Hayek, Joussef ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADOLESCENT; ARTICLE; CHEMISTRY; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DENSITOMETRY; DIET SUPPLEMENTATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ERYTHROCYTE; FEMALE; HEART; HEART MUSCLE; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RETT SYNDROME; SINGLE BLIND PROCEDURE;

ADOLESCENT; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; DENSITOMETRY; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; ECHOCARDIOGRAPHY; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HEART; HUMANS; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOTYPE; RETT SYNDROME; SINGLE-BLIND METHOD;

EID: 84893861482     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/983178     Document Type: Article

References (43)

1. Rett A., On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wiener Medizinische Wochenschrift 1966 116 37 723 726 2-s2.0-0014011176
2. Chahrour M., Zoghbi H. Y., The story of Rett syndrome: from clinic to neurobiology. Neuron 2007 56 3 422 437 2-s2.0-35648978121 10.1016/j.neuron.2007. 10.001 (Pubitemid 350026269)
3. Chahrour M., Sung Y. J., Shaw C., Zhou X., Wong S. T. C., Qin J., Zoghbi H. Y., MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008 320 5880 1224 1229 2-s2.0-45849105557 10.1126/science.1153252 (Pubitemid 351929512)
4. Li Y., Wang H., Muffat J., Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 2013 13 4 446 458
5. De Felice C., Guazzi G., Rossi M., Ciccoli L., Signorini C., Leoncini S., Tonni G., Latini G., Valacchi G., Hayek J., Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study. Chest 2010 138 2 386 392 2-s2.0-77955354404 10.1378/chest.09-3021
6. Caffarelli C., Gonnelli S., Tanzilli L., Hayek J., Vichi V., Franci M. B., Lucani B., Nuti R., The relationship between serum ghrelin and body composition with bone mineral density and QUS parameters in subjects with Rett syndrome. Bone 2012 50 4 830 835 2-s2.0-84858035442 10.1016/j.bone.2012.01.017
7. Gonnelli S., Caffarelli C., Hayek J., Montagnani A., Cadirni A., Franci B., Lucani B., Rossi S., Nuti R., Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. Bone 2008 42 4 737 742 2-s2.0-40849120482 10.1016/j.bone.2007.12.003
8. Cepollaro C., Gonnelli S., Bruni D., Pacini S., Martini S., Franci M. B., Gennari L., Rossi S., Hayek G., Zappella M., Gennari C., Dual X-ray absorptiometry and bone ultrasonography in patients with Rett syndrome. Calcified Tissue International 2001 69 5 259 262 2-s2.0-18044398815 10.1007/s002230010027 (Pubitemid 33140934)
9. Kerr A. M., Armstrong D. D., Prescott R. J., Doyle D., Kearney D. L., Rett syndrome: analysis of deaths in the British survey. European Child & Adolescent Psychiatry 1997 6 supplement 1 71 74 2-s2.0-0031471323 (Pubitemid 28027156)
10. Morita H., Wu J., Zipes D. P., The QT syndromes: long and short. The Lancet 2008 372 9640 750 763 2-s2.0-50149112857 10.1016/S0140-6736(08)61307-0
11. Sekul E. A., Moak J. P., Schultz R. J., Glaze D. G., Percy A. K., Electrocardiographic findings in Rett syndrome: an explanation for sudden death? Journal of Pediatrics 1994 125 1 80 82 2-s2.0-0028235383 10.1016/S0022-3476(94) 70128-8 (Pubitemid 24225185)
12. Acampa M., Guideri F., Cardiac disease and Rett syndrome. Archives of Disease in Childhood 2006 91 5 440 443 2-s2.0-33646377640 10.1136/adc.2005. 090290 (Pubitemid 43672376)
13. McCauley M. D., Wang T., Mike E., Herrera J., Beavers D. L., Huang T.-W., Ward C. S., Skinner S., Percy A. K., Glaze D. G., Wehrens X. H. T., Neul J. L., Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome. Science Translational Medicine 2011 3 113 113 125 2-s2.0-84859733873
14. De Felice C., Maffei S., Signorini C., Subclinical myocardial dysfunction in Rett syndrome. European Heart Journal-Cardiovascular Imaging 2012 13 4 339 345
15. De Felice C., Ciccoli L., Leoncini S., Signorini C., Rossi M., Vannuccini L., Guazzi G., Latini G., Comporti M., Valacchi G., Hayek J., Systemic oxidative stress in classic Rett syndrome. Free Radical Biology and Medicine 2009 47 4 440 448 2-s2.0-67649850376 10.1016/j.freeradbiomed.2009.05.016
16. De Felice C., Signorini C., Durand T., Oger C., Guy A., Bultel-Poncé V., Galano J.-M., Ciccoli L., Leoncini S., D'Esposito M., Filosa S., Pecorelli A., Valacchi G., Hayek J., F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome. Journal of Lipid Research 2011 52 12 2287 2297 2-s2.0-81855217494 10.1194/jlr.P017798
17. Leoncini S., De Felice C., Signorini C., Pecorelli A., Durand T., Valacchi G., Ciccoli L., Hayek J., Oxidative stress in Rett syndrome: natural history, genotype, and variants. Redox Report 2011 16 4 145 153 2-s2.0-80052009849 10.1179/1351000211Y.0000000004
18. Pecorelli A., Ciccoli L., Signorini C., Leoncini S., Giardini A., D'Esposito M., Filosa S., Hayek J., de Felice C., Valacchi G., Increased levels of 4HNE-protein plasma adducts in Rett syndrome. Clinical Biochemistry 2011 44 5-6 368 371 2-s2.0-79952765428 10.1016/j.clinbiochem.2011.01.007
19. Signorini C., De Felice C., Leoncini S., Giardini A., D'Esposito M., Filosa S., Della Ragione F., Rossi M., Pecorelli A., Valacchi G., Ciccoli L., Hayek J., F4-neuroprostanes mediate neurological severity in Rett syndrome. Clinica Chimica Acta 2011 412 15-16 1399 1406 2-s2.0-79956316620 10.1016/j.cca.2011.04.016
20. Durand T., De Felice C., Signorini C., F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome. Biochimie 2013 95 1 86 90
21. De Felice C., Signorini C., Leoncini S., Pecorelli A., Durand T., Valacchi G., Ciccoli L., Hayek J., The role of oxidative stress in Rett syndrome: an overview. Annals of the New York Academy of Sciences 2012 1259 121 135
22. Grillo E., Lo Rizzo C., Bianciardi L., Revealing the complexity of a monogenic disease: Rett syndrome exome sequencing. PLoS ONE 2013 8 2 e56599
23. Griendling K. K., FitzGerald G. A., Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003 108 16 1912 1916 2-s2.0-0142055950 10.1161/01.CIR.0000093660.86242.BB (Pubitemid 37296532)
24. Chen L., Einbinder E., Zhang Q., Hasday J., Balke C. W., Scharf S. M., Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. The American Journal of Respiratory and Critical Care Medicine 2005 172 7 915 920 2-s2.0-25444518908 10.1164/rccm.200504-560OC (Pubitemid 41369077)
25. Mozaffarian D., Wu J. H. Y., Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology 2011 58 20 2047 2067 2-s2.0-79961054708 10.1016/j.jacc.2011.06.063
26. De Felice C., Signorini C., Durand T., Ciccoli L., Leoncini S., D'Esposito M., Filosa S., Oger C., Guy A., Bultel-Poncé V., Galano J.-M., Pecorelli A., De Felice L., Valacchi G., Hayek J., Partial rescue of Rett syndrome by ω -3 polyunsaturated fatty acids (PUFAs) oil. Genes & Nutrition 2012 7 3 447 458 2-s2.0-84857734934 10.1007/s12263-012-0285-7
27. Tarquinio D. C., Motil K. J., Hou W., Lee H. S., Glaze D. G., Skinner S. A., Neul J. L., Annese F., McNair L., Barrish J. O., Geerts S. P., Lane J. B., Percy A. K., Growth failure and outcome in Rett syndrome: specific growth references. Neurology 2012 79 16 1653 1661
28. Neul J. L., Fang P., Barrish J., Lane J., Caeg E. B., Smith E. O., Zoghbi H., Percy A., Glaze D. G., Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 2008 70 16 1313 1321 2-s2.0-42249095974 10.1212/01.wnl.0000291011.54508.aa (Pubitemid 351550354)
29. Neul J. L., Kaufmann W. E., Glaze D. G., Christodoulou J., Clarke A. J., Bahi-Buisson N., Leonard H., Bailey M. E. S., Schanen N. C., Zappella M., Renieri A., Huppke P., Percy A. K., Rett syndrome: revised diagnostic criteria and nomenclature. Annals of Neurology 2010 68 6 944 950 2-s2.0-78650903501 10.1002/ana.22124
30. Ciccoli L., Leoncini S., Signorini C., Comporti M., Valacchi G., Davis P., Iron and erythrocytes: physiological and pathophysiological aspects. Oxidants in Biology: A Question of Balance 2008 Springer 167 181
31. Signorini C., De Felice C., Durand T., Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder. Oxidative Medicine and Cellular Longevity 2013 2013 10 343824 10.1155/2013/343824
32. Galano J. M., Mas E., Barden A., Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans. Prostaglandins and Other Lipid Mediators 2013 107 95 102
33. Nourooz-Zadeh J., Gopaul N. K., Barrow S., Mallet A. I., Anggård E. E., Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. Journal of Chromatography B 1995 667 2 199 208 2-s2.0-0028988943 10.1016/0378-4347(95)00035-H
34. Signorini C., Comporti M., Giorgi G., Ion trap tandem mass spectrometric determination of F2-isoprostanes. Journal of Mass Spectrometry 2003 38 10 1067 1074 2-s2.0-0242438091 10.1002/jms.520 (Pubitemid 37407701)
35. Valacchi G., Pecorelli A., Signorini C., Leoncini S., Ciccoli L., De Felice C., Hayek J., Patel V., Martin C., Preedy V., Preedy V., 4HNE protein adducts in autistic spectrum disorders: Rett syndrome and autism. Comprehensive Guide to Autism 2013 Berlin, Germany Springer
36. Serhan C. N., Chiang N., van Dyke T. E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology 2008 8 5 349 361 2-s2.0-42649089790 10.1038/nri2294 (Pubitemid 351595216)
37. Arnold C., Markovic M., Blossey K., Wallukat G., Fischer R., Dechend R., Konkel A., Von Schacky C., Luft F. C., Muller D. N., Rothe M., Schunck W.-H., Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of ω -3 fatty acids. The Journal of Biological Chemistry 2010 285 43 32720 32733 2-s2.0-77958484254 10.1074/jbc.M110.118406
38. Zhang G., Panigrahy D., Mahakian L. M., Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proceedings of the National Academy of Sciences of the United States of America 2013 110 16 6530 6535
39. De Felice C., Signorini C., Leoncini S., Fatty acids and autism spectrum disorders: the Rett syndrome conundrum. Food Nutrition Sciences 2013 4 71 75
40. Buchovecky C. M., Turley S. D., Brown H. M., A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nature Genetics 2013 45 9 1013 1020
41. Sticozzi C., Belmonte G., Pecorelli A., Cervellati F., Leoncini S., Signorini C., Ciccoli L., De Felice C., Hayek J., Valacchi G., Scavenger receptor B1 post-translational modifications in Rett syndrome. FEBS Letters 2013 587 14 2199 2204
42. Ferguson J. F., Mulvey C. K., Patel P. N., Shah R. Y., Doveikis J., Zang W., Tabita-Martinez J., Terembula K., Eiden M., Koulman A., Griffin J. L., Mehta N. N., Shah R., Propert K. J., Song W. L., Reilly M. P., Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Molecular Nutrition & Food Research 2013 10.1002/mnfr.201300368
43. Alvarez-Saavedra M., Carrasco L., Sura-Trueba S., Aiello V. D., Walz K., Neto J. X., Young J. I., Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. Human Molecular Genetics 2010 19 11 2177 2190 2-s2.0-77953533210 10.1093/hmg/ddq096 ddq096